Stock data
Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX) reported net income of -US$34.26M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$27.97M | -US$34.26M | — |
| 2024 | — | — | -US$12.23M | -US$12.35M | — |
| 2023 | — | — | -US$5.45M | -US$5.30M | — |
| 2022 | — | — | -US$12.32M | -US$12.25M | — |
| 2021 | — | — | -US$15.64M | -US$15.96M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$11.53M | — |
| 2026-03-31 | — | -US$4.99M | — |
| 2025-12-31 | — | -US$3.78M | — |
| 2025-09-30 | — | -US$15.74M | — |
| 2025-06-30 | — | -US$3.81M | — |
| 2025-03-31 | — | -US$10.92M | — |
| 2024-12-31 | — | -US$7.73M | — |
| 2024-09-30 | — | -US$2.28M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.